Differentiated human intestinal Caco-2 cells are frequently used in toxicology and pharmacology as in vitro models for studies on intestinal barrier functions. Since several discrepancies exist among the different lines and clones of Caco-2 cells, comparison of the results obtained and optimisation of models for use for regulatory purposes are particularly difficult, especially with respect to culture conditions and morphological and biochemical parameters. An inter-laboratory study has been performed on the parental cell line and on three clonal Caco-2 cell lines, with the aim of standardising the culture conditions and identifying the best cell line with respect to parameters relevant to barrier integrity, namely, transepithelial electrical resistance (TEER) and mannitol passage, and of epithelial differentiation (alkaline phosphatase activity). Comparison of the cell lines maintained in traditional serum-supplemented culture medium or in defined medium, containing insulin, transferrin, selenium and lipids, showed that parameter performance was better and more reproducible with the traditional medium. The maintenance of the cell lines for 15 days in culture was found to be sufficient for the development of barrier properties, but not for full epithelial differentiation. Caco-2/TC7 cells performed better than the other three cell lines, both in terms of reproducibility and performance, exhibiting low TEER and mannitol passage, and high alkaline phosphatase activity.
Anon. (2001). White paper on a Strategy for a Future Chemicals Policy. COM(2001) 88 final. 32 pp. Brussels, Belgium: Commission of the European Communities.
2.
Anon. (2003). Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximations of the laws of the Member States relating to cosmetic products. Official Journal of the European UnionL66, 26–35.
3.
FoghJ., FoghJ.M., & OrfeoT. (1977). One hundred and twenty seven cultured human tumour cell lines producing tumours in nude mice. Journal of the National Cancer Institute59, 221–226.
4.
PintoM., Robine-LeonS., AppayM.D., KedingerM., TradouN., DussaulxE., LacroixB., Simon-AssmanP., HaffenK., FoghJ., & ZweibaumA. (1983). Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biology of the Cell47, 323–330.
5.
MatsumotoH., EricksonR.H., GumJ.R., YoshiokaM., GumE., & KimY.S. (1990). Biosynthesis of alkaline phosphatase during differentiation of the human colon cancer cell line Caco-2. Gastroenterology98, 1199–1207.
6.
LevyP., RobertA., & PicardJ. (1988). Biosynthesis of glycosaminoglycans in the human colonic tumor cell line Caco-2: structural changes occurring with the morphological differentiation of the cells. Biology of the Cell62, 255–264.
7.
LevyP., CherquiG., RobertA., WicekD., & PicardJ. (1989). Changes in glycosaminoglycan sulfation and protein kinase C subcellular distribution during differentiation of the human colon tumor cell line Caco-2. Experientia45, 588–591.
8.
HidalgoI.J., RaubT.J., & BorchardtR.T. (1989). Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology96, 736–749.
9.
SambuyY., De AngelisI., RanaldiG., ScarinoM.L., StammatiA., & ZuccoF. (2005). The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biology and Toxicology21, 1–26.
10.
BjorgeS., HamelehleK.L., HomanR., RoseS.E., TurluckD.A., & WrightD.S. (1991). Evidence for glucuronide conjugation of p-nitrophenol in the Caco-2 cell model. Pharmacological Research8, 1441–1443.
11.
Baranczyk-KuzmaA., GarrenJ.A., HidalgoI.J., & BorchardtR.T. (1991). Substrate specificity and some properties of phenol sulfotransferase from human intestinal Caco-2 cells. Life Sciences49, 1197–1206.
12.
BoulencX., BourrieM., FabreI., RoqueC., JoyeuxH., BergerY., & FabreG. (1992). Regulation of cytochrome P4501A1 gene expression in a human intestinal cell line, Caco-2. Journal of Pharmacology and Experimental Therapeutics263, 1471–1478.
13.
PetersW.H.M., & RoelofsH.M.J. (1992). Biochemical characterisation of resistance to mitoxantrone and adriamycin in Caco-2 human colon carcinoma cells: a possible role of glutathione-S-transferase. Cancer Research52, 1886–1890.
14.
PrueksaritanontT., GorhamL.M., HochmanJ.H., TranL.O., & VyasK.P. (1996). Comparative studies of drug-metabolising enzymes in dog, monkey and human small intestines and in Caco-2 cells. Drug Metabolism and Disposition24, 634–642.
15.
LampenA., BaderA., BestmannT., WinklerM., WitteL., & BorlakJ.T. (1998). Catalytic activities, protein and mRNA expression of cytochrome P450 isoenzymes in intestinal cell lines. Xenobiotica28, 429–441.
16.
AugustijnsP., AnnaertP.P.H., Van den MooterG., & KingetR. (1998). Drug absorption studies of pro-drug esters using the Caco-2 model: evaluation of ester hydrolysis and transepithelial transport. International Journal of Pharmaceutics166, 45–53.
17.
De AngelisI., VincentiniO., BrambillaG., StammatiA., & ZuccoF. (1998). Characterization of furazolidone apical-related effects to human polarized intestinal cells. Toxicology and Applied Pharmacology152, 119–127.
18.
ChantretI., BarbatA., DussaulxE., BrattainM.G., & ZweibaumA. (1988). Epithelial polarity, villin expression and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. Cancer Research48, 1936–1942.
19.
HarrisD.S., SlotJ.W., GeuzeH.J., & JamesD.E. (1992). Polarized distribution of glucose transporter isoforms in Caco-2 cells. Proceedings of the National Academy of Sciences USA89, 7556–7560.
20.
EngleM.J., GoetzG.S., & AlpersD.H. (1998). Caco-2 cells express a combination of colonocyte and enterocyte phenotypes. Journal of Cell Physiology174, 362–369.
21.
SambuyY., FerruzaS., RanaldiG., & De AngelisI. (2001). Intestinal cell culture models. Applications in toxicology and pharmacology. Cell Biology and Toxicology17, 301–317.
22.
DelieF., & RubasW. (1997). A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: Advantages and limitations of the Caco-2 model. Critical Review in Therapeutic Drug Carrier Systems14, 221–286.
23.
ArturssonP., PalmK., & LuthmanK. (2001). Caco-2 monolayers in experimental and theoretical predictions of drug transport. Advanced Drug Delivery Reviews46, 27–43.
24.
ISS/ECVAM (2003). Final Report of Development and refinement of a Caco-2 cell in vitro model of intestinal barrier function. Contract number ISS/ECVAM 17299-2000-12. Website http://ecvam.jrc.it
25.
MadaraJ. (1998). Regulation of the movement of solutes across tight junctions. Annual Review of Physiology60, 143–159.
26.
SpringK. (1998). Routes and mechanism of fluid transport by epithelia. Annual Review of Physiology60, 105–119.
27.
SussmanN.L., EliakimR., RubinD., PerlmutterD.H., Deschryver-KeckemetiK., & AlpersD.H. (1989). Intestinal alkaline phosphatase is secreted bidirectionally from villous enterocytes. American Journal of Physiology275, G14–G23.
28.
ChantretI., RodolosseA., BarbatA., DussaulxE., Brot-LarocheE., ZweibaumA., & RoussetM. (1994). Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation. Journal of Cell Science107, 213–225.
29.
BeaulieuJ-F., & QuaroniA. (1991). Clonal analysis of sucrase-isomaltase expression in the human colon adenocarcinoma Caco-2 cells. Biochemical Journal280, 599–608.
30.
ChirayathM.V., GajdzikL., HullaW., GrafJ., CrossH.S., & PeterlikM. (1998). Vitamin D increases tight-junction conductance and paracellular Ca2+ transport in Caco-2 cell cultures. American Journal of Physiology274, G389–396.
31.
MorelE., DemignoteS., ChateauD., ChambazJ., RoussetM., & DelersF. (2004). Lipid-dependent bidirectional traffic of apolipoprotin B in polarized enterocytes. Molecular Biology of the Cell15, 132–141.
32.
LowryO.H., RosenbroughN.J., FarrA.L., & RandallR.I. (1951). Protein measurement with the folin phenol reagent. Journal of Biological Chemistry193, 265–275.
33.
BradfordM. (1976). A rapid sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein dye binding. Analytical Biochemistry72, 248–254.
34.
BallsM., BlaauboerB.J., FentemJ.H., BrunerL., CombesR.D., EkwallB., FielderR.J., GuillouzoA., LewisR.W., LovellD.P., ReinhardtC.A., RepettoG., SladowskiD., SpielmannH., & ZuccoF. (1995). Practical aspects of the validation of toxicity test procedures. ATLA23, 129–147.
35.
ArturssonP. (1990). Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. Journal of Pharmaceutical Science79, 476–482.
36.
TsukitaS., & FuruseM. (1999). Occludin and claudins in tight-junction strands: leading or supporting players?Trends in Cell Biology9, 268–273.
